发明名称 |
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FLUPIRTINE |
摘要 |
This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with flupirtine. This invention also provides a package and a pharmaceutical composition comprising laquinimod and flupirtine for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with flupirtine in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and flupirtine in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. |
申请公布号 |
EP3027188(A1) |
申请公布日期 |
2016.06.08 |
申请号 |
EP20140832928 |
申请日期 |
2014.07.30 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
SILVER, DAVID;ROMACH, EINAT AMIT |
分类号 |
A61K31/4704;A61K31/44;A61P25/00;A61P37/00 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|